# ALSET INC. (AEI) · Edgar & Edgarette company card

> Alset (AEI) saw revenue fall 78.8% in FY2025 to $4 million, operating margin -339% against a 21.1% median for real estate, equity 88.6% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1750106 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/AEI) · [JSON](https://www.pops4.com/boards/company/AEI.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $4M |
| Revenue growth, 1 year | -78.8% |
| Revenue growth per year | -31.1% |
| Operating margin | -338.9% (prior year -19.5%) |
| Net margin | -1103.8% |
| Operating cash flow | −$6M |
| Capital spending | $175,464 |
| Free cash flow | −$6M |
| Cash | $25M |
| Long-term debt | — |
| Total assets | $137M |
| Total equity | $121M |
| Equity ÷ assets | 88.6% |
| Return on equity | -40.8% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Piotroski F: 1 of 9 (weak)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative; operating loss: a margin of -338.9% in FY2025; revenue is hard to predict: its 80% range is ±53%
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $4.5M (FY2025). Experience: revenue down 78.8% on the year, down 31.1% a year over 4 years; operating margin -338.9%, down from -19.5%. Soundness: equity 88.6% of assets, return on equity -40.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $1.5M and $4.8M next year (method v4.1: its own 3-year record of growth weighed at 40% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $1.4M to $5.2M. A statistical range, not company guidance. Against peers (8 filers, $50M+ revenue, real estate): operating margin -338.9% against a 21.1% median; growth -78.8% against 6.1%.

Range logged 2026-09-24, receipt dd8cb10943df5319, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-10-30 ([filing](https://www.sec.gov/Archives/edgar/data/1750106/000149315226049459/0001493152-26-049459-index.htm))

## Recent filings

- 8-K · filed 2026-10-30 · 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule · [filing](https://www.sec.gov/Archives/edgar/data/1750106/000149315226049459/0001493152-26-049459-index.htm)
- DEF 14A · filed 2026-10-20 · [filing](https://www.sec.gov/Archives/edgar/data/1750106/000149315226047636/0001493152-26-047636-index.htm)
- 8-K · filed 2026-09-21 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1750106/000149315226043566/0001493152-26-043566-index.htm)
- 10-Q · filed 2026-08-14 · [filing](https://www.sec.gov/Archives/edgar/data/1750106/000149315226038402/0001493152-26-038402-index.htm)
- 8-K · filed 2026-06-25 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1750106/000149315226030176/0001493152-26-030176-index.htm)
- 10-Q · filed 2026-05-14 · [filing](https://www.sec.gov/Archives/edgar/data/1750106/000149315226023104/0001493152-26-023104-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001750106.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1750106

## Cite

POPS4, Edgar & Edgarette: ALSET INC. (AEI) company card, from the company's own SEC filings, accessed 2026-11-06, https://www.pops4.com/boards/company/AEI. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.